Clinical spectrum and features of activated phosphoinositide 3-kinase syndrome: Alarge patient cohort study
暂无分享,去创建一个
J. Casanova | S. Nejentsev | P. Palma | C. Cancrini | A. Šedivá | S. Ehl | C. Feighery | A. Durandy | S. Faust | S. Burns | B. Grimbacher | K. Imai | P. Gavin | D. Moshous | Anthony P. Williams | A. Condliffe | H. Baxendale | Anita Chandra | R. Doffinger | H. Longhurst | J. Goodlad | S. Savic | C. Speckmann | R. Hague | G. Hayman | R. Herriot | A. Cant | N. Conlon | C. Bacon | M. Abinun | J. Babar | Z. Kucuk | J. Bernatoniene | P. Forsyth | M. Ibrahim | F. Touzot | Alain Fischer | I. Pellier | J. D. Edgar | J. Curtis | R. Brooker | T. Leahy | George Farmer | C. Steele | T. Coulter | P. Ariganello | A. Jones | T. Milota | P. French | sper Markelj | Nick Screaton
[1] B. Vanhaesebroeck,et al. Phosphoinositide 3-kinase p110δ promotes lumen formation through the enhancement of apico-basal polarity and basal membrane organization , 2015, Nature Communications.
[2] B. Eickholt,et al. Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes , 2014, Journal of Medical Genetics.
[3] J. Hughes,et al. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K , 2014, The Journal of experimental medicine.
[4] É. Oksenhendler,et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. , 2014, The Journal of allergy and clinical immunology.
[5] J. Lammers,et al. CT Screening for Pulmonary Pathology in Common Variable Immunodeficiency Disorders and the Correlation with Clinical and Immunological Parameters , 2014, Journal of Clinical Immunology.
[6] A. Zelenetz,et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. , 2014, The New England journal of medicine.
[7] G. Salles,et al. PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma. , 2014, The New England journal of medicine.
[8] S. Pittaluga,et al. Mutations in PIK3CD Can Cause Hyper IgM Syndrome (HIGM) Associated with Increased Cancer Susceptibility , 2014, Journal of Clinical Immunology.
[9] S. Pittaluga,et al. Mutations in PIK3CD Can Cause Hyper IgM Syndrome (HIGM) Associated with Increased Cancer Susceptibility , 2014, Journal of Clinical Immunology.
[10] J. B. Oliveira,et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency , 2013, Nature Immunology.
[11] David Dunson,et al. Genetic heterogeneity of diffuse large B-cell lymphoma , 2013, Proceedings of the National Academy of Sciences.
[12] Francesco Papaleo,et al. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy , 2012, Proceedings of the National Academy of Sciences.
[13] A. Fischer,et al. Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency , 2011, Front. Immun..
[14] J. Liese,et al. Reference values for B cell subpopulations from infancy to adulthood , 2010, Clinical and experimental immunology.
[15] B. Wolska-Kuśnierz,et al. B cell subsets in healthy children: Reference values for evaluation of B cell maturation process in peripheral blood , 2010, Cytometry. Part B, Clinical cytometry.
[16] B. Vanhaesebroeck,et al. Regulation of phosphoinositide 3-kinase expression in health and disease. , 2009, Trends in biochemical sciences.
[17] É. Oksenhendler,et al. Infections in 252 patients with common variable immunodeficiency. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] N. Müller,et al. Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.
[19] A. Need,et al. Control of Axonal Growth and Regeneration of Sensory Neurons by the p110δ PI 3-Kinase , 2007, PloS one.
[20] A. Plebani,et al. Long-Term Follow-Up and Outcome of a Large Cohort of Patients with Common Variable Immunodeficiency , 2007, Journal of Clinical Immunology.
[21] Y. Chien,et al. Identification of variations in the human phosphoinositide 3‐kinase p110δ gene in children with primary B‐cell immunodeficiency of unknown aetiology , 2006, International journal of immunogenetics.
[22] R. Geha,et al. The X-Linked Hyper-IgM Syndrome: Clinical and Immunologic Features of 79 Patients , 2003, Medicine.
[23] B. Vanhaesebroeck,et al. Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta. , 2003, Cancer research.
[24] D. Kumararatne,et al. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. , 2002, QJM : monthly journal of the Association of Physicians.
[25] David G Milne,et al. Thin-section CT in obstructive pulmonary disease: discriminatory value. , 2002, Radiology.
[26] C. Cunningham-Rundles,et al. Common variable immunodeficiency: clinical and immunological features of 248 patients. , 1999, Clinical immunology.
[27] Jonathan A. Cooper,et al. p110δ, a Novel Phosphatidylinositol 3-Kinase Catalytic Subunit That Associates with p85 and Is Expressed Predominantly in Leukocytes* , 1997, The Journal of Biological Chemistry.
[28] M. Zvelebil,et al. p110δ, a novel phosphoinositide 3-kinase in leukocytes , 1997 .
[29] R de Groot,et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. , 1997, The Journal of pediatrics.
[30] Patrick Nitschke,et al. A human immunodeficiency caused by mutations in the PIK3R1 gene. , 2015, The Journal of clinical investigation.
[31] C. Galambos. Common variable immunodeficiency disorders: division into distinct clinical phenotypes , 2009 .